DelMar Pharmaceuticals Inc (DMPI)
NASDAQ
Year End June 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -124.371 | -151.008 | -146.31 | -261.935 | -503.659 | -153.681 | -150.74 | -166.997 |
Return on Equity (%) | -155.132 | -188.364 | -219.643 | -819.283 | -765.474 | -202.547 | -239.805 | -378.832 |
Return on Invested Capital (%) | -145.2 | -185.6 | -226.479 | -856.69 | -481.93 | -249.582 | -298.126 | -376.604 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.011 | -0.043 | -0.784 | -0.396 | -0.133 | -0.012 | -5.859 | -0.117 |
Earnings Per Share | -0.611 | -0.493 | -2.117 | -0.797 | -1.268 | -0.346 | -8.876 | -0.154 |
Cash Per Share | 0.454 | 0.26 | 0.969 | 0.209 | 0.322 | 0.18 | 0.907 | 0.089 |
Working Capital Per Share | 0.453 | 0.235 | 0.509 | 0.015 | 0.275 | 0.141 | 0.111 | 0.059 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.557 | -0.485 | -2.096 | -0.796 | -1.17 | -0.346 | -8.658 | -0.15 |
EBITDA Per Share | -0.557 | -0.485 | -2.096 | -0.796 | -1.17 | -0.346 | -8.658 | -0.15 |
Free Cash Flow Per Share | -0.611 | -0.493 | -2.122 | -0.798 | -1.268 | -0.347 | -8.775 | -0.154 |
Year End June 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 14.51M | 22.97M | 3.84M | 11.46M | 32.74M | 65.53M | N/A | N/A |
Year End June 29 2024 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 80.81M | 1.67M | N/A | N/A | 3.39M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 74.11M |
Price to Earnings Ratio | -49.06 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 84.91 |
Price to Book Ratio | 110.99 |
Dividend Yield | - |
Shares Outstanding | 55.31M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.